Holders

TRAVERE THERAPEUTICS INC

Q3 2025 13F holders

CUSIP
89422GAA5
Type
Debt
Class
NOTE 2.250% 3/0
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Principal Option type